NEUROPACE, INC. Revenue
NEUROPACE, INC. (NPCE) reported Revenue of $22.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-11
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $22.83M, a 17.05% increase year-over-year.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $22.07M, a 2.02% decline year-over-year.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $26.59M, a 23.86% increase year-over-year.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $27.35M, a 29.89% increase year-over-year.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $99.99M, a 25.13% increase from fiscal 2024.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $79.91M, a 22.14% increase from fiscal 2023.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $65.42M, a 43.72% increase from fiscal 2022.
- NEUROPACE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $45.52M, a 0.75% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22.83M 10-Q · filed 2026-08-11 | $44.83M 10-Q · filed 2026-08-11 | $71.48M derived: sum of 3 quarters · filed 2026-08-11 | $98.84M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $22.07M 10-Q · filed 2026-05-12 | $48.66M derived: sum of 2 quarters · filed 2026-05-12 | $76.01M derived: sum of 3 quarters · filed 2026-05-12 | $95.51M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $26.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $53.94M derived: sum of 2 quarters · filed 2026-03-03 | $73.44M derived: sum of 3 quarters · filed 2026-08-11 | $99.99M 10-K · filed 2026-03-03 | ||
| 2025-09-30 | $27.35M 10-Q · filed 2025-11-04 | $46.85M derived: sum of 2 quarters · filed 2026-08-11 | $73.40M 10-Q · filed 2025-11-04 | $90.84M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $19.50M 10-Q · filed 2026-08-11 | $23.52M 10-Q · filed 2025-08-12 | $37.82M 10-Q · filed 2026-08-11 | $46.04M 10-Q · filed 2025-08-12 | $63.49M derived: sum of 3 quarters · filed 2026-08-11 | $84.55M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $22.52M 10-Q · filed 2026-05-12 | $43.99M derived: sum of 2 quarters · filed 2026-05-12 | $65.05M derived: sum of 3 quarters · filed 2026-05-12 | $84.31M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $21.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $42.53M derived: sum of 2 quarters · filed 2026-03-03 | $61.78M derived: sum of 3 quarters · filed 2026-03-03 | $79.91M 10-K · filed 2026-03-03 | ||
| 2024-09-30 | $21.06M 10-Q · filed 2025-11-04 | $40.32M derived: sum of 2 quarters · filed 2025-11-04 | $58.44M 10-Q · filed 2025-11-04 | $76.45M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $19.26M 10-Q · filed 2025-08-12 | $37.38M 10-Q · filed 2025-08-12 | $55.39M derived: sum of 3 quarters · filed 2025-08-12 | $71.82M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $18.12M 10-Q · filed 2025-05-13 | $36.14M derived: sum of 2 quarters · filed 2025-05-13 | $52.56M derived: sum of 3 quarters · filed 2025-05-13 | $69.07M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $18.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $34.44M derived: sum of 2 quarters · filed 2025-03-04 | $50.95M derived: sum of 3 quarters · filed 2025-03-04 | $65.42M 10-K · filed 2025-03-04 | ||
| 2023-09-30 | $16.43M 10-Q · filed 2024-11-12 | $32.94M derived: sum of 2 quarters · filed 2024-11-12 | $47.41M 10-Q · filed 2024-11-12 | $60.20M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $16.51M 10-Q · filed 2024-08-13 | $30.98M 10-Q · filed 2024-08-13 | $43.77M derived: sum of 3 quarters · filed 2024-08-13 | $54.93M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $14.47M 10-Q · filed 2024-05-08 | $27.26M derived: sum of 2 quarters · filed 2024-05-08 | $38.42M derived: sum of 3 quarters · filed 2024-05-08 | $48.62M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $12.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $23.95M derived: sum of 2 quarters · filed 2024-03-05 | $34.15M derived: sum of 3 quarters · filed 2024-03-05 | $45.52M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $11.16M 10-Q · filed 2023-11-06 | $21.36M derived: sum of 2 quarters · filed 2023-11-06 | $32.73M 10-Q · filed 2023-11-06 | $43.73M derived: sum of 4 quarters · filed 2023-11-06 | ||
| 2022-06-30 | $10.20M 10-Q · filed 2023-08-08 | $21.57M 10-Q · filed 2023-08-08 | $32.57M derived: sum of 3 quarters · filed 2023-08-08 | $42.91M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $11.37M 10-Q · filed 2023-05-04 | $22.37M derived: sum of 2 quarters · filed 2023-05-04 | $32.71M derived: sum of 3 quarters · filed 2023-05-04 | $45.34M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $21.34M derived: sum of 2 quarters · filed 2023-03-02 | $33.97M derived: sum of 3 quarters · filed 2023-03-02 | $45.18M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $10.34M 10-Q · filed 2022-11-08 | $22.97M derived: sum of 2 quarters · filed 2022-11-08 | $34.19M 10-Q · filed 2022-11-08 | $44.94M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $12.63M 10-Q · filed 2022-08-11 | $23.85M 10-Q · filed 2022-08-11 | $34.60M derived: sum of 3 quarters · filed 2022-08-11 | $47.37M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $11.22M 10-Q · filed 2022-05-12 | $21.97M derived: sum of 2 quarters · filed 2022-05-12 | $34.74M derived: sum of 3 quarters · filed 2022-05-12 | $42.38M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $10.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $23.52M derived: sum of 2 quarters · filed 2022-03-10 | $31.16M derived: sum of 3 quarters · filed 2022-03-10 | $41.14M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $12.77M 10-Q · filed 2021-11-10 | $20.41M derived: sum of 2 quarters · filed 2021-11-10 | $30.39M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $7.64M 10-Q · filed 2021-08-12 | $17.61M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $9.97M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |